Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines

Oncogene

Volumn 23, Issue 54, 2004, Pages 8796-8804

  Tanami, Hideaki ^a   Imoto, Issei ^a,b   Hirasawa, Akira ^a   Yuki, Yasuhiro ^a   Sonoda, Itaru ^a   Inoue, Jim ^a,b   Yasui, Kohichiro ^a,b   Misawa Furihata, Akiko ^a,b   Kawakami, Yutaka ^c   Inazawa, Johji ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

BRAF; Comparative genomic hybridization; Gene amplification; Malignant melanoma; Mutation

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAF PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CHROMOSOME 7Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WILD TYPE;

BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 7; GENES, RAS; HUMANS; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NUCLEIC ACID HYBRIDIZATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS B-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 9944235462     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208152     Document Type: Article

References (32)

1. Ariyama Y, Sakabe T, Shinomiya T, Mori T, Fukuda Y and Inazawa J. (1998). J. Hum. Genet., 43, 187-190.
2. Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J and Adany R. (2001). Cytometry, 46, 222-232.
3. Bastian BC, LeBoit PE, Hamm H, Brocker EB and Pinkel D. (1998). Cancer Res., 58, 2170-2175.
4. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR and Weber BL. (2002). Cancer Res., 62, 6997-7000.
5. Calipel A, Lefevre G, Pouponnot C, Mouriaux F, Eychene A and Mascarelli F. (2003). J. Biol. Chem., 278, 42409-42418.
6. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, Cordon-Cardo C, Yancopoulos GD and DePinho RA. (1999). Nature, 400, 468-472.
7. Chong H, Vikis HG and Guan KL. (2003). Cell Signal., 15, 463-469.
8. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J. Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA. (2002). Nature, 417, 949-954.
9. Edmunds SC, Cree IA, Di Nicolantonio F, Hungerford JL, Hurren JS and Kelsell DP. (2003). Br. J. Cancer, 88, 1403-1405.
10. Fukuda Y, Kurihara N, Imoto I, Yasui K, Yoshida M, Yanagihara K, Park J-G, Nakamura Y and Inazawa Y. (2000). Genes Chromosomes Cancer, 29, 315-324.
11. Herlyn M, Berking C, Li G and Satyamoothy K. (2000). Melanoma Res., 10, 303-312.
12. Hoa M, Davis SL, Ames SJ and Spanjaard RA. (2002). Cancer Res., 62, 7154-7156.
13. Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M, Ohki M and Inazawa J. (2001). Cancer Res., 61, 6629-6634.
14. Imoto I, Yuki Y, Sonoda I, Ito T, Shimada Y, Imamura M and Inazawa J. (2003). Cancer Res., 63, 5691-5696.
15. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D. (1992). Science, 258, 818-821.
16. Kukita A and Ishihara K. (1989). J. Investig. Dermatol., 92, 210S-213S.
17. Kumar R, Angelini S and Hemminki K. (2003). Oncogene, 22, 9217-9224.
18. Mercer KE and Pritchard CA. (2003). Biochim. Biophys. Acta, 1653, 25-40.
19. Metzelaar-Blok JA, Jager MJ, Moghaddam PH, van der Slik AR and Giphart MJ. (1999). Hum. Immunol., 60, 962-969.
20. Peyssonnaux C and Eyche'ne A. (2001). Biol. Cell, 93, 53-62.
21. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hosteller G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM and Meltzer PS. (2003). Nat. Genet., 33, 19-20.
22. Roelofs H, Mostert MC, Pompe K, Zafarana G, van Oorschot M, van Gurp RJ, Gillis AJ, Stoop H, Beverloo B, Oosterhuis JW, Bokemeyer C and Looijenga LH. (2000). Am. J. Pathol., 157, 1155-1166.
23. Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T and Inazawa J. (2003). Cancer Res., 63, 1876-1883.
24. Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van Belle P, Elder DE and Herlyn M. (2003). Cancer Res., 63, 756-759.
25. Sauter ER and Herlyn M. (1998). Mol. Carcinogen., 23, 132-148.
26. Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herlyn M and Bastian BC. (2002). Cancer Res., 62, 3200-3206.
27. Smalley KSM. (2003). Int. J. Cancer, 104, 527-532.
28. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S and Inazawa J. (2004). Cancer Res., 64, 3741-3747.
29. Tuveson DA, Weber BL and Herlyn M. (2003). Cancer Cell, 4, 95-99.
30. Vogelstein B and Kinzler KW. (1993). Trends Genet., 9, 138-141.
31. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D and Marais R. (2004). Cell, 116, 855-867.
32. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M and Inazawa J. (2002). Hepatology, 35, 1476-1484.